StockData
MiMedx Group, Inc. logo

MiMedx Group, Inc. (MDXG) stock

MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)

Close on Nov 17, 2026Market cap $464.04MP/E –Yield –

MiMedx total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

MiMedx's total debt was $0 at Sep 30, 2026. For fiscal 2025 it was $17.97M, down 4.6% from the year before. Over ten years it grew 16.6% a year on average. The highest annual figure on record is $65.66M in fiscal 2019.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$17.97M-4.6%
FY2024Dec 31, 2024$18.83M-61.6%
FY2023Dec 31, 2023$49.10M+1.0%
FY2022Dec 31, 2022$48.59M+1.0%
FY2021Dec 31, 2021$48.13M+0.9%
FY2020Dec 31, 2020$47.70M-27.4%
FY2019Dec 31, 2019$65.66M–
FY2018Dec 31, 2018$0–
FY2013Dec 31, 2013$0-100.0%
FY2012Dec 31, 2012$4.01M+3.6%
FY2011Dec 31, 2011$3.87M–
FY2010Dec 31, 2010$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$0-100.0%
Q2 FY2026Jun 30, 2026$17.21M-6.8%
Q1 FY2026Mar 31, 2026$17.59M-5.7%
Q4 FY2025Dec 31, 2025$17.97M-4.6%
Q3 FY2025Sep 30, 2025$18.21M-4.2%
Q2 FY2025Jun 30, 2025$18.46M-4.1%
Q1 FY2025Mar 31, 2025$18.66M-4.1%
Q4 FY2024Dec 31, 2024$18.83M-61.6%
Q3 FY2024Sep 30, 2024$19.02M-61.2%
Q2 FY2024Jun 30, 2024$19.25M-60.6%
Q1 FY2024Mar 31, 2024$19.45M-60.1%
Q4 FY2023Dec 31, 2023$49.10M+1.0%
Q3 FY2023Sep 30, 2023$48.97M+1.0%
Q2 FY2023Jun 30, 2023$48.84M+1.0%
Q1 FY2023Mar 31, 2023$48.71M+1.0%
Q4 FY2022Dec 31, 2022$48.59M+1.0%
Q3 FY2022Sep 30, 2022$48.48M+1.0%
Q2 FY2022Jun 30, 2022$48.36M+0.9%
Q1 FY2022Mar 31, 2022$48.24M+0.9%
Q4 FY2021Dec 31, 2021$48.13M+0.9%
Q3 FY2021Sep 30, 2021$48.02M+0.8%
Q2 FY2021Jun 30, 2021$47.91M-26.6%
Q1 FY2021Mar 31, 2021$47.80M-26.9%
Q4 FY2020Dec 31, 2020$47.70M-27.4%
Q3 FY2020Sep 30, 2020$47.63M-27.8%
Q2 FY2020Jun 30, 2020$65.22M-2.4%
Q1 FY2020Mar 31, 2020$65.39M–
Q4 FY2019Dec 31, 2019$65.66M–
Q3 FY2019Sep 30, 2019$65.92M–
Q2 FY2019Jun 30, 2019$66.82M–
Q4 FY2018Dec 31, 2018$0–

More MiMedx figures

See a number that looks wrong?